Search
Displaying results 661 to 670 of 683.
Infection Immunology
An infection can be seen as a fight between a microbe and our body’s defence mechanisms. The microbe is trying to multiply and disseminate, while the different components of our immune system will work together trying to stop this process. This is not an easy mission for our body because microbes have learned how to hide, evade or even destroy some of the components of the immune system as well as how to resist antibiotic treatment. The focus of our research is to understand the battle between microbes and our immune defences. If we know the different tricks and mechanisms employed by the microbes to breach our defences we will be able to design new strategies to counteract and disarm the attacking microorganisms.
Immune Regulation
Due to their physiological functions our mucosal surfaces are in direct contact to the environment and thus represent the major port of entry for pathogens. To protect the body from severe infections an effective mucosal immune system is indispensable. We are studying respiratory tract infections with the focus on influenza and pneumococci, which represent the most frequent viral and bacterial infectious agents for pneumonia in humans. A major focus of our research is to study molecular and cellular processes during coinfection with influenza and pneumococci and here in particular the immunological functions of the alveolar epithelium in host defense.
Actinobacteria Metabolic Engineering
The growing resistance towards established antibiotics presents a serious problem especially with infectious diseases. The development of new drugs is mainly based on known molecules and mechanisms, which allows bacteria to assimilate rapidly. Hence, scientists are looking for novel drugs. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) , a site of the Helmholtz Centre for Infection Research (HZI) at Braunschweig, the researchers develop new pathways, by which they force actinomycetes to produce hitherto unknown compounds.
LncRNA and Infection Biology
RNA is a truly remarkable molecule with functions and activities far beyond that of an intermediate information carrier. The abundant class of long non-coding RNAs (lncRNAs) contains highly specialized RNA with structural or regulatory functions that range from assembling large protein complexes to localizing, sequestering, or allosterically modifying proteins and other interaction partners. Our genome contains thousands of lncRNAs, many of which are specifically regulated during bacterial or viral infections. However, their contribution to launching and sustaining an effective host response remains elusive. Our group combines a cutting-edge suite of technologies from the fields of biochemistry, genomics, molecular biology, and computational biology to decode how lncRNA work mechanistically and how they contribute to host defense mechanisms. This group is located at the Helmholtz Institute for RNA-based Infection Research (HIRI).
Experimental Virology
Viruses are tiny vehicles that transport biological information to reprogram the functions of human, animal, or plant cells in order to replicate. So-called "enveloped" viruses consist of only one layer of proteins, are filled with genetic material, and are surrounded by a thin shell of lipids in which viral proteins are embedded. Even though viruses are tiny and have a simple build, viral pathogens such as the hepatitis C virus (HCV), respiratory syncytial virus (RSV), and SARS-CoV-2 have the potential to threaten the health of millions of people. Here at the Institute for Experimental Virology, we focus on fundamental and translational RNA virus research. Our research groups combine the expertise of molecular and cell biological approaches with computational methods to help elucidate viral replication mechanisms to develop new therapeutic and preventive strategies.
Experimental Infection Research
If we are attacked by a virus, the immune system reacts within a matter of hours. Highly specialized immune cells recognise the pathogen and release highly efficient messengers, which activate the immune system. These messengers include the interferons, which ensure that individual host cells are mildly infected . At the same time, interferons can also influence the course of the immune response and the memory of the immune system. Without these messengers virus infections - which we normally overcome almost unnoticeably - become fatal within just a few days. The group Experimental Infection Research is based at the TWINCORE in Hannover.
Microbial Immune Regulation
The microbiota encompasses a diverse population of microorganisms that colonize many body sites such as skin and intestine of multicellular hosts. The composition of the microbiota in humans is highly variable and is influenced by nutrition, immune competence, illness and use of medication (especially antibiotics). We are interested to enhance our understanding on how these microbial communities affect human infectious diseases and how they can be manipulated to treat diseases.
Cellular Metabolism in Infection
With a focus on applying mass spectrometry and tracing approaches, the research group “Cellular Metabolism in Infection” (CMII) headed by Prof Thekla Cordes tracks metabolic pathways, leading to discoveries about the role of small molecules influencing immune cell metabolism and function.
Genome Mining for Secondary Metabolites
The misuse of antibiotics on a global scale has led to an ever-growing antibiotic resistance crisis. Novel antimicrobial compounds are urgently needed. Microorganisms are considered to be one of the most prolific sources for natural product drugs including antibiotics. Developing novel genome mining approaches to harness the potential of the underexplored biosynthetic gene pathways and discover novel microbial natural products, is a potential antibiotic resistance crisis mitigation path. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .
Human-Microbe Systems Bioinformatics
The human body encompasses fewer human cells than microbes. They constantly interact with each other and the host and greatly affect an individual's health and well-being. In our group, we develop and apply state-of-the-art bioinformatics software to study the human-microbe systems and aim to discover natural products involved in communication between the two realms. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .